Adam Keeney

BIIB

Adam Keeney serves as Head of Corporate Development at Biogen Inc. (BIIB). This page tracks their complete SEC Form 4 insider trading history including stock purchases and sales.

Total Buys

0 trades

$0.00

Total Sells

4 trades

$512.6K

Net Position

Net Seller

$512.6K

Companies Traded

BIIB

Active Period

May 2024 – Feb 2026

4 total trades

Most Recent

Sell BIIB

Feb 6, 2026 · $318.5K

Adam Keeney's Insider Trading at Biogen Inc. (BIIB)

Buys

0 · $0.00

Sells

4 · $512.6K

Total Shares Bought

Total Shares Sold

2,876

BIIB Price Chart

Loading chart...

Date	Type	Shares	Avg Price	Value
Feb 6, 2026	Sell	1,583	$201.18	$318.5K
May 5, 2025	Sell	454	$120.93	$54.9K
Feb 10, 2025	Sell	563	$141.35	$79.6K
May 1, 2024	Sell	276	$216.13	$59.7K

Related Insiders

Nicole Murphy

officer: Head of Pharm Ops and Tech

BIIBBuy · Feb 17, 2026

Sean Godbout

Chief Accounting Officer

BIIBSell · Feb 6, 2026

Ginger Gregory

EVP, Human Resources

BIIBSell · Feb 6, 2026

Jane Grogan

Head of Research

BIIBSell · Feb 6, 2026

Rachid Izzar

Head of Global Product Strat.

BIIBSell · Feb 6, 2026

Robin Kramer

Chief Financial Officer

BIIBSell · Feb 6, 2026

Christopher Viehbacher

President and CEO

BIIBSell · Feb 6, 2026

ALEXANDER SUSAN H

EVP Chief Legal Officer

BIIBSell · Feb 6, 2026

Explore More Insider Trading Data

BIIB Insider Trading Activity

View all insider trades at Biogen Inc.

Healthcare Sector Insider Trades

See insider activity across healthcare stocks

Latest Insider Buys

Most recent insider purchases across all stocks

CEO Stock Purchases

Track CEO buying activity